Peres academic center, College in Rehovot, Israel

Jerusalem, Jan 18 More than 90 per cent of Covid patients treated with Pfizer's antiviral drug Paxlovid showed significant improvement within three days, according to a report.The report by Israel's Maccabi Healthcare Services showed that of the individuals who received Paxlovid, 60 per cent started to feel better within the first day, Jerusalem Post reported."We recommend to anyone who has fallen sick with Covid and is found suitable for the treatment with this drug to take it and get protected against a serious illness that can lead to hospitalisation and even death," Maccabi division head Dr. Miri Mizrahi Reuveni was quoted as saying."The results of the survey indicate the quality of the treatment, its effectiveness and importance during the fight against the coronavirus pandemic, and especially in the midst of the current wave," she said.Israel started administering Paxlovid on January 3.The treatment involves taking three pills twice a day for five days, starting as soon as possible and no later than five days after the patient shows the first symptoms.It is intended for individuals in mild to moderate condition who are considered at high risk of developing serious illness.Data from Pfizer's clinical trial showed that when the treatment was started within three days of the first symptoms, hospitalisations and deaths dropped by 89 per cent compared with a placebo.In the survey, about 62 per cent participants said they suffered from side effects. Of these one-third experienced a bitter metallic taste, 18 per cent had diarrhoea, 11 per cent reported a loss in taste or smell, 7 per cent had muscle aches, and 4 per cent experienced a headache. So far, no patient who has received Paxlovid has died, the report said.As per data by the Israeli Health Ministry as of last week, almost a third of patients did not accept the treatment - 753 refusals compared with 1,623 who accepted the drug.A significant number of those who refused the treatment might also be unvaccinated, which is also considered a high-risk factor, suggest data from Meuhedet Health Maintenance Organization.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Peres Academic CenterFOLLOW

Peres academic center, Latest News

Jerusalem, Jan 27 Israel has launched a 225-million-shekel ($70.8 million) programme to boost high-tech developments in the Arab ... ...

Jerusalem, Jan 27 Israel on Wednesday signed the Artemis Accords and joined the US-led programme to land human ... ...

Tel Aviv, Jan 24 Israel's cabinet has decided to launch a state investigation into the procurement of submarines ... ...

Delhi Police on Monday said it has solved a case of cryptocurrency theft by busting a cyber fraud module operated by Al-Qassam Brigates, the military wing of Hamas, which operated by hacking into crypto-wallets of people and transferring the stolen v ...

Tel Aviv, Jan 24 The Israeli Cabinet has approved the launching of an Israeli-Emirati industrial research and development ... ...

Music can unite believers across the globe and is undoubtedly a divine creation and is primarily a special gift from God. The power of music is used to communicate, express gratitude and appreciate God's presence in our lives. Gospel music leads our ...

Israel has condemned the terrorist attacks in Abu Dhabi and expressed condolences to the government and people of India after two Indian nationals were killed in the incident. ...

Jerusalem, Jan 18 More than 90 per cent of Covid patients treated with Pfizer's antiviral drug Paxlovid showed ... ...